The effects of particle properties on nanoparticle drug retention and release in dynamic minoxidil foams

International Journal of Pharmaceutics

Volumn 383, Issue 1-2, 2010, Pages 277-284

  Zhao, Yanjun ^a   Brown, Marc B ^b,c   Jones, Stuart A ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b MEDPHARM LTD   (United Kingdom)

^c UNIVERSITY OF HERTFORDSHIRE   (United Kingdom)

Author keywords

Drug release; Foam; Minoxidil; Nanoparticles; Permeation; Vehicle

Indexed keywords

FLUORINATED HYDROCARBON; LIPID NANOPARTICLE; MINOXIDIL; NANOPARTICLE; POLOXAMER; UNCLASSIFIED DRUG;

AQUEOUS SOLUTION; ARTICLE; CONTROLLED DRUG RELEASE; CONTROLLED STUDY; DRUG FORMULATION; DRUG PENETRATION; DRUG SOLUBILITY; DRUG STORAGE; FOAM; MEMBRANE TRANSPORT; PARTICLE SIZE; PHYSICAL CHEMISTRY; PRIORITY JOURNAL; SUSPENSION; THERMODYNAMICS;

DELAYED-ACTION PREPARATIONS; DRUG CARRIERS; HYDROCARBONS, FLUORINATED; MINOXIDIL; NANOPARTICLES; PARTICLE SIZE; SUSPENSIONS;

EID: 70449716932     PISSN: 03785173     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2009.09.029     Document Type: Article

References (37)

1. Alvarez-Roman R., Naik A., Kalia Y.N., Guy R.H., and Fessi H. Skin penetration and distribution of polymeric nanoparticles. J. Control Release 99 (2004) 53-62
2. Barry B.W. Drug delivery routes in skin: a novel approach. Adv. Drug. Deliv. Rev. 54 (2002) S31-S40
3. Cohen-Sela E., Chorny M., Koroukhov N., Danenberg H.D., and Golomb G. A new double emulsion solvent diffusion technique for encapsulating hydrophilic molecules in PLGA nanoparticles. J. Control Release 133 (2009) 90-95
4. Cronin M.T.D., Dearden J.C., Gupta R., and Moss G.P. An investigation of the mechanism of flux across polydimethylsiloxane membranes by use of quantitative structure-permeability relationships. J. Pharm. Pharmacol. 50 (1998) 143-152
5. Cross S.E., Innes B., Roberts M.S., Tsuzuki T., Robertson T.A., and McCormick P. Human skin penetration of sunscreen nanoparticles: in-vitro assessment of a novel micronized zinc oxide formulation. Skin Pharmacol. Physiol. 20 (2007) 148-154
6. Cross S., Pugh W.J., Hadgraft J., and Roberts M. Probing the effect of vehicles on topical delivery: understanding the basic relationship between solvent and solute penetration using silicone membranes. Pharm. Res. 18 (2001) 999-1005
7. Dingler A., Blum R.P., Niehus H., Muller R.H., and Gohla S. Solid lipid nanoparticles (SLN (TM)/lipopearls (TM))-a pharmaceutical and cosmetic carrier for the application of vitamin E in dermal products. J. Microencapsul. 16 (1999) 751-767
8. Fessi H., Puisieux F., Devissaguet J.P., Ammoury N., and Benita S. Nanocapsule formation by interfacial polymer deposition following solvent displacement. Int. J. Pharm. 55 (1989) R1-R4
9. Geinoz S., Rey S., Boss G., Bunge A.L., Guy R.H., Carrupt P.A., Reist M., and Testa B. Quantitative structure-permeation relationships for solute transport across silicone membranes. Pharm. Res. 19 (2002) 1622-1629
10. Govender T., Stolnik S., Garnett M.C., Illum L., and Davis S.S. PLGA nanoparticles prepared by nanoprecipitation: drug loading and release studies of a water soluble drug. J. Control Release 57 (1999) 171-185
11. Heng D., Cutler D.J., Chan H.K., Yun J., and Raper J.A. What is a suitable dissolution method for drug nanoparticles?. Pharm. Res. 25 (2008) 1696-1701
12. Henry K.S., Wieland W.H., Powell D.E., and Giesy J.P. Laboratory analyses of the potential toxicity of sediment-associated polydimethylsiloxane to benthic macroinvertebrates. Environ. Toxicol. Chem. 20 (2001) 2611-2616
13. Heurtault B., Saulnier P., Pech B., Proust J.E., and Benoit J.P. A novel phase inversion-based process for the preparation of lipid nanocarriers. Pharm. Res. 19 (2002) 875-880
14. Higuchi T. Physical chemical analysis of percutaneous absorption process from creams and ointments. J. Soc. Cosmet. Chem. 11 (1960) 85-97
15. Hillaireau H., Le Doan T., and Couvreur P. Polymer-based nanoparticles for the delivery of nucleoside analogues. J. Nanosci. Nanotechnol. 6 (2006) 2608-2617
16. Ishihara T., Takahashi M., Higaki M., and Mizushima Y. Efficient encapsulation of a water-soluble corticosteroid in biodegradable nanoparticles. Int. J. Pharm. 365 (2009) 200-205
17. Jenning V., and Gohla S.H. Encapsulation of retinoids in solid lipid nanoparticles (SLN (R)). J. Microencapsul. 18 (2001) 149-158
18. Jenning V., SchSfer-Korting M., and Gohla S. Vitamin A-loaded solid lipid nanoparticles for topical use: drug release properties. J. Control Release 66 (2000) 115-126
19. Lademann J., Richter H., Schaefer U.F., Blume-Peytavi U., Teichmann A., Otberg N., and Sterry W. Hair follicles-a long-term reservoir for drug delivery. Skin Pharmacol. Physiol. 19 (2006) 232-236
20. Lademann J., Richter H., Teichmann A., Otberg N., Blume-Peytavi U., Luengo J., Weiss B., Schaefer U.F., Lehr C.M., Wepf R., and Sterry W. Nanoparticles-an efficient carrier for drug delivery into the hair follicles. Eur. J. Pharm. Biopharm. 66 (2007) 159-164
21. Luengo J., Weiss B., Schneider M., Ehlers A., Stracke F., Konig K., Kostka K.H., Lehr C.M., and Schaefer U.F. Influence of nanoencapsulation on human skin transport of flufenamic acid. Skin Pharmacol. Physiol. 19 (2006) 190-197
22. Mehnert W., and Mader K. Solid lipid nanoparticles: production, characterization and applications. Adv. Drug Deliv. Rev. 47 (2001) 165-196
23. Moffat A.C., Osselton M.D., and Widdop B. Monographs: Minoxidil. Clarke's Analysis of Drugs and Poisons: In Pharmaceuticals, Body Fluids, and Postmortem Material. 3rd ed. (2004), Pharmaceutical Press, London pp. 1288
24. Muller R.H., Radtke M., and Wissing S.A. Solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC) in cosmetic and dermatological preparations. Adv. Drug Deliv. Rev. 54 (2002) S131-S155
25. Musumeci T., Ventura C.A., Giannone I., Ruozi B., Montenegro L., Pignatello R., and Puglisi G. PLA/PLGA nanoparticles for sustained release of docetaxel. Int. J. Pharm. 325 (2006) 172-179
26. Pardeike J., Hommoss A., and Muller R.H. Lipid nanoparticles (SLN, NLC) in cosmetic and pharmaceutical dermal products. Int. J. Pharm. 366 (2009) 170-184
27. Puglia C., Blasi P., Rizza L., Schoubben A., Bonina F., Rossi C., and Ricci M. Lipid nanoparticles for prolonged topical delivery: an in vitro and in vivo investigation. Int. J. Pharm. 357 (2008) 295-304
28. Schafer-Korting M., Mehnert W., and Korting H.C. Lipid nanoparticles for improved topical application of drugs for skin diseases. Adv. Drug Deliv. Rev. 59 (2007) 427-443
29. Sciarra J.J., and Cutie A.J. In: Lieberman H.A., Rieger M.M., and Banker G.S. (Eds). Aerosol Suspensions and Emulsions (1996), Dekker, New York 319-355
30. Shim J., Seok Kang H., Park W.S., Han S.H., Kim J., and Chang I.S. Transdermal delivery of mixnoxidil with block copolymer nanoparticles. J. Control Release 97 (2004) 477-484
31. Souto E.B., and Muller R.H. Cosmetic features and applications of lipid nanoparticles (SLN, NLC). Int. J. Cosmet. Sci. 30 (2008) 157-165
32. Stracke F., Weiss B., Lehr C.M., Koenig K., Schaefer U.F., and Schneider M. Multiphoton microscopy for the investigation of dermal penetration of nanoparticle-borne drugs. J. Invest. Dermatol. 126 (2006) 2224-2233
33. Tamarkin, D., Friedman, D., Eini, M., Besonov, A., 2005. Cosmetic and pharmaceutical foam with solid matter. US Patent 20,050,186,147, 25 August.
34. Wissing S.A., Muller R.H., Manthei L., and Mayer C. Structural characterization of Q10-loaded solid lipid nanoparticles by NMR spectroscopy. Pharm. Res. 21 (2004) 400-405
35. Zhao, Y., Jones, S.A., Brown, M.B., 2008. Topical formulations. U.K. Patent GB0715646.6, 10 August.
36. Zhao Y., Moddaresi M., Jones S.A., and Brown M.B. A dynamic topical hydrofluoroalkane foam to induce nanoparticle modification and drug release in situ. Eur. J. Pharm. Biopharm. 72 (2009) 521-528
37. zur Muhlen A., Schwarz C., and Mehnert W. Solid lipid nanoparticles (SLN) for controlled drug delivery-drug release and release mechanism. Eur. J. Pharm. Biopharm. 45 (1998) 149-155